Adiponectin is Associated with Impaired Fasting Glucose in the Non-Diabetic Population
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: Adiponectin is strongly associated with diabetes in the Western population. However, whether adiponectin is independently associated with impaired fasting glucose (IFG) in the non-obese population is unknown. METHODS: The serum adiponectin, insulin resistance (IR), and waist circumference (WC) of 27,549 healthy Koreans were measured. Individuals were then classified into tertile groups by gender. IFG was defined as a fasting serum glucose of 100-125 mg/dL without diabetes. IR was calculated using the homeostasis model assessment of insulin resistance (HOMA-IR). The association of adiponectin and IFG was determined using logistic regression analysis. RESULTS: WC and adiponectin were associated with IFG in both men and women. However, the association of WC with IFG was attenuated in both men and women after adjustment for the HOMA-IR. Adiponectin was still associated with IFG after adjustment for and stratification by HOMA-IR in men and women. Strong combined associations of IR and adiponectin with IFG were observed in men and women. Multivariate adjusted odds ratios (ORs) (95% confidence interval [CI]) among those in the highest tertile of IR and the lowest tertile of adiponectin were 9.8 (7.96 to 12.07) for men and 24.1 (13.86 to 41.94) for women. CONCLUSION: These results suggest that adiponectin is strongly associated with IFG, and point to adiponectin as an additional diagnostic biomarker of IFG in the non-diabetic population.
Abstract
OBJECTIVES: Adiponectin is strongly associated with diabetes in the Western population. However, whether adiponectin is independently associated with impaired fasting glucose (IFG) in the non-obese population is unknown. METHODS: The serum adiponectin, insulin resistance (IR), and waist circumference (WC) of 27,549 healthy Koreans were measured. Individuals were then classified into tertile groups by gender. IFG was defined as a fasting serum glucose of 100-125 mg/dL without diabetes. IR was calculated using the homeostasis model assessment of insulin resistance (HOMA-IR). The association of adiponectin and IFG was determined using logistic regression analysis. RESULTS: WC and adiponectin were associated with IFG in both men and women. However, the association of WC with IFG was attenuated in both men and women after adjustment for the HOMA-IR. Adiponectin was still associated with IFG after adjustment for and stratification by HOMA-IR in men and women. Strong combined associations of IR and adiponectin with IFG were observed in men and women. Multivariate adjusted odds ratios (ORs) (95% confidence interval [CI]) among those in the highest tertile of IR and the lowest tertile of adiponectin were 9.8 (7.96 to 12.07) for men and 24.1 (13.86 to 41.94) for women. CONCLUSION: These results suggest that adiponectin is strongly associated with IFG, and point to adiponectin as an additional diagnostic biomarker of IFG in the non-diabetic population.
참고문헌 (29)
- "Diabetes programme"[URL]
- The Asia-Pacific perspective: redefining obesity and its treatment, "Bassett J", Health Communications Australia, ~ (2000)
- Korea Centers for Disease Control and Prevention, "The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008" (2009), Ministry for Health, Welfare and Family Affairs
- Wong MS, "The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward", Diabetes Care, 26, pp.3024~303 (2003)
- 엄홍대, "규칙적 운동과 제 2형 당뇨병 발생에 관한 전향적 코호트 연구- 공복혈당장애군을 대상으로", 예방의학회지, 41(1), pp.45~50 (2008), 대한예방의학회
- Valensi P, "Pre-diabetes essential action: a European perspective", Diabetes Metab, 31, pp.606~620 (2005)
- Meigs JB, "Baltimore Longitudinal Study of Aging. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging", Diabetes, 52, pp.1475~1484 (2003)
- Lecomte P, "Five-year predictive factors of type 2 diabetes in men with impaired fasting glucose", Diabetes Metab, 33, pp.140~147 (2007)
- Qian Y, "The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population", BMC Public Health, 10, pp.139~ (2010)
- Baena-Díez JM, "Waist circumference and impaired fasting glucose screening in a Mediterranean population", Diabetes Res Clin Pract, 86, pp.e12~e14 (2009)
- Chang SA, "Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea", Metabolism, 53, pp.142~146 (2004)
- 박이병, "우리나라 당뇨병의 역학적 특성 -대한당뇨병학회·건강보험심사평가원 공동연구 결과를 중심으로", Diabetes and Metabolism Journal, 33(5), pp.357~362 (2009), 대한당뇨병학회
- Yoon SJ, "The association between adiponectin and diabetes in the Korean population", Metabolism, 57, pp.853~857 (2008)
- Yun JE, "Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients", Diabetes Metab Res Rev, 25, pp.259~265 (2009)
- Arita Y, "Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity", Biochem Biophys Res Commun, 257, pp.79~83 (1999)
- Weyer C, "Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia", J Clin Endocrinol Metab, 86, pp.1930~1935 (2001)
- Yamamoto Y, "Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population", Clin Sci (Lond), 103, pp.137~142 (2002)
- Jee SH, "Development of ELISA-kit of quantitative analysis for adiponectin and their correlation with cardiovascular risk factors", Korean J Epidemiol, 29, pp.165~175 (2007)
- Ruderman N, "The metabolically obese, normal-weight individual revisited", Diabetes, 47, pp.699~713 (1998)
- Hotta K, "Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys", Diabetes, 50, pp.1126~1133 (2001)
- Yamauchi T, "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity", Nat Med, 7, pp.941~946 (2001)
- Nilsson PM, "Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance", Arterioscler Thromb Vasc Biol, 26, pp.2758~2762 (2006)
- Duncan BB, "Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study", Diabetes, 53, pp.2473~2478 (2004)
- Greenfield JR, "Relationship between inflammation, insulin resistance and type 2 diabetes: ‘cause or effect’", Curr Diabetes Rev, 2, pp.195~211 (2006)
- Shand BI, "Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study", Int J Obes (Lond), 33, pp.1274~1279 (2009)
- Knobler H, "Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose", Eur J Endocrinol, 154, pp.87~92 (2006)
- Choi KM, "Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans", Clin Endocrinol (Oxf), 61, pp.75~80 (2004)
- Wang Z, "Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults", Diabetes Metab Res Rev, 26, pp.109~114 (2010)
- Snijder MB, "Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study", Diabetes Care, 29, pp.2498~2503 (2006)
